Last reviewed · How we verify
CE Ferulic — Competitive Intelligence Brief
phase 2
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
CE Ferulic (CE Ferulic) — Goldman, Butterwick, Fitzpatrick and Groff. CE Ferulic is a topical antioxidant serum combining vitamin C, vitamin E, and ferulic acid to neutralize free radicals and protect skin from oxidative damage.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| CE Ferulic TARGET | CE Ferulic | Goldman, Butterwick, Fitzpatrick and Groff | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- CE Ferulic CI watch — RSS
- CE Ferulic CI watch — Atom
- CE Ferulic CI watch — JSON
- CE Ferulic alone — RSS
Cite this brief
Drug Landscape (2026). CE Ferulic — Competitive Intelligence Brief. https://druglandscape.com/ci/ce-ferulic. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing